Bioavailability of Dexlansoprazole MR 90 mg When Administered as Granules Sprinkled on Soft Foods

Trial Profile

Bioavailability of Dexlansoprazole MR 90 mg When Administered as Granules Sprinkled on Soft Foods

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Oct 2013

At a glance

  • Drugs Dexlansoprazole (Primary)
  • Indications Erosive oesophagitis; Gastro-oesophageal reflux
  • Focus Pharmacokinetics
  • Sponsors Takeda
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top